According to the report, the global oral thin films market was valued at US$ 2.6 Bn in 2019.
Oral Thin Films Market: Introduction
According to the report, the global oral thin films market was valued at US$ 2.6 Bn in 2019. It is projected to expand at a CAGR of ~9% from 2020 to 2030. Oral thin film drug is a promising drug delivery dosage form, which delivers drugs by adhering to the oral mucosa.
Rise in demand for thin film drug delivery systems, considerable research & development, and strategic alliances between novel technology owners and large pharmaceutical companies are major factors that are anticipated to drive the global oral thin films market during the forecast period. North America held a major share of the global oral thin films market in 2019, due to higher penetration of the oral thin film technology and increase in focus on new product launches by industry players in the region.
The oral thin films market in Europe is expected to expand at a high CAGR of 11.2% from 2020 to 2030, due to increase in the number of geriatric patients suffering from dysphagia and rise in oral thin film introductions in the region.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=42869
Rising Demand for Thin Film Drug Delivery System to Drive Market
The demand for thin film drug delivery system is rising due to benefits such as larger surface area, precision medication, and pleasant color & flavor over traditional drug delivery systems. Thin film drugs are reported to be the preferred choice of patients as well as medical practitioners, as they are more patient-friendly and offer good quality results. Oral thin film drugs offer high compliance to patients, and ease of storage and transportation. Moreover, these offer precise and accurate dosing with the desired effective outcome. Hence, the thin film drug delivery system market has recorded substantial attractiveness. High acceptance level and impressive advantages have further propelled the global oral thin film market.
Sublingual Films Dominated Global Market
In terms of product, the global oral thin films market has been classified into sublingual film, fast dissolving oral film, and buccal film. The sublingual film segment dominated the global oral thin films market in 2019, and the trend is projected to continue during the forecast period. Significant research activities, strong product pipeline, and high market adoption of sublingual film are expected to boost the segment during the forecast period.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=42869
High Prevalence of Neurological Disorders to Drive Global Market
In terms of indication, the global oral thin films market has been categorized into pain management, neurological disorders, nausea & vomiting, opioid dependence, and others. The neurological disorders segment held a major share of the global oral thin films market in 2019. Rise in prevalence of neurological disorders is expected to drive the segment during the forecast period. According to the data published by the National Center for Biotechnology Information, the mean prevalence of neurological disorders was around 2,394 per 100,000 population in India.
Retail Pharmacies to be Major Distribution Channel
Based on distribution channel, the global oral thin films market has been divided into hospital pharmacies, retail pharmacies, and online pharmacies. The retail pharmacies segment dominated the market in 2019, owing to higher preference for retail pharmacies among end users, easy availability of a wide range of products, and increase in the number of retail pharmacies in developing countries.
North America to Dominate Global Market; Europe to Offer Significant Opportunities
In terms of region, the global oral thin films market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is projected to account for a leading share of the global oral thin films market during the forecast period. Higher penetration of oral thin films, availability of the products, and presence of a large number of suppliers compared to other regions are the major factors driving the market in the region.
Buy Oral Thin Films Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=42869<ype=S
The market in Asia Pacific is expected to expand at a high CAGR in the near future, owing to the presence of local as well as global players and an increase in the demand for oral thin films in the region. The oral thin films market in Europe is likely to expand at a rapid pace in the near future. Japan and China are anticipated to be lucrative markets for oral thin films during the forecast period. Presence of large geriatric patient population with dysphagia and increase in healthcare expenditure in these countries are projected to propel the market in Asia Pacific over the next few years.
Growth Strategies of Key Market Players
Key players operating in the global oral thin films market are ZIM Laboratories Limited, Indivior plc, Aquestive Therapeutics, Inc., LIVKON Pharmaceuticals pvt. Ltd., Shilpa Therapeutics Pvt. Ltd, Sunovion Pharmaceuticals, Inc., NAL Pharma, Cure Pharmaceutical, IntelGenx Corp., Dr. Reddy’s Laboratories, Kyu Pharmaceutical Co Ltd, Seoul PharmaCo, and C.L. Pharm. These companies engage in research & development to develop novel products in order to expand product offerings and customer base. In January 2021, Cure Pharmaceutical received the U.S. FDA approval for CUREfilm Blue for the treatment of erectile dysfunction (ED). It increased the commercial opportunity for Cure Pharmaceutical in the U.S.
More Trending Reports by Transparency Market Research:
Veterinary Drugs Market: Transparency Market Research (TMR) forecasts the market to exhibit a CAGR of 5.1% between 2016 and 2024. At this pace, the market which stood at US$17.2 bn in 2015, is forecast to reach US$26.7 bn by the end of 2024.
Photopheresis Products Market: According to Transparency Market Research’s latest report on the global photopheresis products market for the historical period 2017–2018 and forecast period 2019–2027. The global photopheresis products market is driven by increase in increase in organ transplantations, increase in cutaneous T-cell lymphoma and favorable reimbursement policies.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/